Sinclair Pharma has posted a financial year sales growth of 51%, to £37.8m ($47.2m), compared to 2015 numbers, which stood at £25m. The company said it had achieved this by increasing its production capacity from 550,000 pills per annum in 2014 to 1.1m tablets and capsules last year. * FY sales growth of 51% at £37.8 million, (2015: £25.0 million, 18 months £45.5 million) The company's board expects 2017 earnings before interest, taxes, depreciation and amortisation to be positive.
Sinclair Pharma has posted a financial year sales growth of 51%, to £37.8m ($47.2m), compared to 2015 numbers, which stood at £25m. The company said it had achieved this by increasing its production capacity from 550,000 pills per annum in 2014 to 1.1m tablets and capsules last year. The company's board expects 2017 earnings before interest, taxes, depreciation and amortisation to be positive.